REFERENCES
- Richards, A., Abreu, B. E., BockStahler, E. R. and Wright, D. L.: General pharmacology of 4-butoxy-p-(1-piperidyl) propiophenone hydrochloride. Federation Proc. 11:20; 317; 385, 1952.
- Phillips, Robert (Pitman-Moore Research Laboratories): Personal communication to the authors.
- Abreu, B. E., Richards, A. and Burch, G. R.: Nervous system effects of 4-alkoxyl-p-(1-piperidyl) propiophenone. Federation Proc. 11:317, 1952.
- Arora, S. B. and Sharma, V. N.: Local anesthetic and pharmacologic properties of 4-n-butoxy-p-(1-piperidyl) propiophenone hydrochloride and diethylaminoethyl p-n-hexyloxybenzilate hydrochloride. J. Pharmacol. & Exper. Therap. (In press.)
- Pitman-Moore Company (research files): Clinical reports on topical use of Dyclone In man.
- Florestano, H. J. and Baylor, M. D.: (To be published.)
- Abreu, B. E., Richards, A. B., Weaver, L. C., Burch, G. R., Bunde, C. A., Bockstahler, E. R. and Wright, D. L.: Pharmacologic properties of 4-alkoxy-p-(1-piperidyl) propiophenone. J. Pharmacol. & Exper. Therap. (In press.)
- Shelmire, B., Gastineau, F. M. and Shields, T. L.: Evaluation of a new topical anesthetic, dyclonine hydrochloride. Arch. Dermat. 71:728–730, 1955.